BUSINESS● LOW4h ago · Oct 13, 2026, 6:10 PM
FTC wants Martin Shkreli held in contempt for trading pharma stocks
Seeking Alpha Tech · north america
The Federal Trade Commission (FTC) is seeking to hold Martin Shkreli in contempt for allegedly trading pharmaceutical stocks. This represents a legal challenge concerning his financial activities in the pharma industry.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS28m agoPickleball franchisor files for bankruptcy as CEO admits ‘that’s on us’ for business mistakeThe Independent WorldBUSINESS30m agoWells Fargo outlines $50B ± 2026 net interest income and ~$13B Q4 net interest income while planning stablecoins in H1 2027Seeking Alpha Tech